يعرض 1 - 16 نتائج من 16 نتيجة بحث عن '"Ann Åsberg"', وقت الاستعلام: 0.47s تنقيح النتائج
  1. 1

    المصدر: Leukemia. 34:347-357

  2. 2
  3. 3

    المساهمون: Clinicum, Lastentautien yksikkö, Children's Hospital, HUS Children and Adolescents

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    المصدر: Svahn, T, Mellgren, K, Harila-Saari, A, Asberg, A, Kanerva, J, Jonsson, O, Vaitkeviciene, G, Mikkelssen, T S, Schmiegelow, K & Heldrup, J 2017, ' Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia ', Pediatric Blood & Cancer, vol. 64, no. 7, 26395 . https://doi.org/10.1002/pbc.26395

  9. 9
  10. 10

    المساهمون: Children's Hospital, Clinicum, HUS Children and Adolescents

    المصدر: Pediatric Blood & Cancer
    Borssén, M, Haider, Z, Landfors, M, Norén-Nyström, U, Schmiegelow, K, Åsberg, A E, Kanerva, J, Madsen, H O, Marquart, H, Heyman, M, Hultdin, M, Roos, G, Forestier, E & Degerman, S 2016, ' DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia ', Pediatric Blood & Cancer, vol. 63, no. 7, pp. 1185-92 . https://doi.org/10.1002/pbc.25958

    وصف الملف: application/pdf

  11. 11
  12. 12

    المصدر: European journal of haematology. 96(2)

  13. 13

    المصدر: Toft, N, Birgens, H, Abrahamsson, J, Bernell, P, Griškevičius, L, Hallböök, H, Heyman, M, Holm, M S, Hulegårdh, E, Klausen, T W, Marquart, H V H, Jónsson, O G, Nielsen, O J, Quist-Paulsen, P, Taskinen, M, Vaitkeviciene, G, Vettenranta, K, Åsberg, A & Schmiegelow, K 2013, ' Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol ', European Journal of Haematology, vol. 90, no. 5, pp. 404-12 . https://doi.org/10.1111/ejh.12097

  14. 14

    المصدر: Frandsen, T, Kanerva, J, Hasle, H, Harila-Saari, A, Wesenberg, F, Åsberg, A, Söderhäll, S, Norén-Nyström, U, Vaitkeviciene, G, Heyman, M, Albertsen, B K, Lund, B, Helt, L & Schmiegelow, K 2011, ' Serious adverse events (SAE´s) and suspected unexpected serious adverse reactions (SUSAR´s) during first 3 years of NOPHO ALL-2008. ', NOPHO, Turku, Finland, 01/05/2011 .
    Aarhus University

  15. 15
  16. 16